1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Are soluble E-selectin, ICAM-1, and VCAM-1 potential predictors for the development of diabetic retinopathy in young adults, 15-34 years of age? A Swedish prospective cohort study
(
- Contribution to journal › Article
- 2023
-
Mark
A comparison in women with newly diagnosed diabetes between those with and without a history of gestational diabetes : a new perspective
(
- Contribution to journal › Article
- 2022
-
Mark
Structural and immunoendocrine remodeling in gut, pancreas and thymus in weaning rats fed powdered milk diets rich in Maillard reactants
(
- Contribution to journal › Article
-
Mark
Does a gluten-free diet lead to better glycemic control in children with type 1 diabetes? Results from a feasibility study and recommendations for future trials
(
- Contribution to journal › Article
-
Mark
HbA1c levels and circulating inflammatory proteins at onset of type 1 diabetes in children and adolescents
(
- Contribution to journal › Article
- 2021
-
Mark
Galectin-3, metalloproteinase-2 and cardiovascular disease were independently associated with metalloproteinase-14 in patients with type 1 diabetes : a cross sectional study
(
- Contribution to journal › Article
-
Mark
Galectin-3 Binding Protein, Depression, and Younger Age Were Independently Associated With Alexithymia in Adult Patients With Type 1 Diabetes
(
- Contribution to journal › Article
- 2020
-
Mark
Pregnancy-associated plasma protein-A2 levels are increased in early-pregnancy gestational diabetes : a novel biomarker for early risk estimation
(
- Contribution to journal › Article
-
Mark
Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes : a cross-sectional study
(
- Contribution to journal › Article
-
Mark
Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes : a comparative cross-sectional study
(
- Contribution to journal › Article